Cargando…
M.tuberculosis Mutants Lacking Oxygenated Mycolates Show Increased Immunogenicity and Protective Efficacy as Compared to M. bovis BCG Vaccine in an Experimental Mouse Model
The existing vaccine against tuberculosis (M. bovis BCG) exerts some protection against the extrapulmonary forms of the disease, particularly in young children, but is not very effective against the pulmonary form of TB, which often results from the reactivation of a latent M. tuberculosis (M.tb)inf...
Autores principales: | Hedhli, Dorsaf, Denis, Olivier, Barkan, Daniel, Daffé, Mamadou, Glickman, Michael S., Huygen, Kris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3798287/ https://www.ncbi.nlm.nih.gov/pubmed/24146869 http://dx.doi.org/10.1371/journal.pone.0076442 |
Ejemplares similares
-
Increasing the Vaccine Potential of Live M. bovis BCG by Coadministration with Plasmid DNA Encoding a Tuberculosis Prototype Antigen
por: Bruffaerts, Nicolas, et al.
Publicado: (2014) -
Transcriptional and Mycolic Acid Profiling in Mycobacterium bovis BCG In Vitro Show an Effect for c-di-GMP and Overlap Between Dormancy and Biofilms
por: la Cruz, Miguel A. De, et al.
Publicado: (2020) -
Mycobacterium leprae Phenolglycolipid-1 Expressed by Engineered M. bovis BCG Modulates Early Interaction with Human Phagocytes
por: Tabouret, Guillaume, et al.
Publicado: (2010) -
Whole genome sequencing of M.tuberculosis in Kazakhstan: preliminary data
por: Kairov, Ulykbek, et al.
Publicado: (2014) -
Disruption of the SapM locus in Mycobacterium bovis BCG improves its protective efficacy as a vaccine against M. tuberculosis
por: Festjens, Nele, et al.
Publicado: (2011)